| Cardiovascular Function and Risk Factors | Lifetime | 49 | US 36 | 99.90 |
| Diet and metabolism studies | Lifetime | 70 | US 35 | 99.80 |
| Gut microbiota and health | Lifetime | 37 | US 12 | 99.82 |
| Heart Failure Treatment and Management | Lifetime | 27 | US 16 | 99.90 |
| Electrolyte and hormonal disorders | Lifetime | 20 | US 11 | 99.48 |
| Cardiac pacing and defibrillation studies | Lifetime | 106 | US 55 | 99.58 |
| Potassium and Related Disorders | Lifetime | 21 | US 13 | 99.44 |
| Mechanical Circulatory Support Devices | Lifetime | 191 | US 116 | 99.02 |
| Cardiac Structural Anomalies and Repair | Lifetime | 249 | US 168 | 99.23 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 176 | US 86 | 98.95 |
| Dialysis and Renal Disease Management | Lifetime | 168 | US 80 | 99.07 |
| Hemodynamic Monitoring and Therapy | Lifetime | 165 | US 60 | 98.68 |
| Cardiac Fibrosis and Remodeling | Lifetime | 118 | US 52 | 97.99 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 170 | US 84 | 97.72 |
| Acute Kidney Injury Research | Lifetime | 188 | US 85 | 97.84 |
| Apelin-related biomedical research | Lifetime | 84 | US 31 | 97.11 |
| Acute Myocardial Infarction Research | Lifetime | 542 | US 243 | 98.37 |
| Erythropoietin and Anemia Treatment | Lifetime | 137 | US 58 | 97.60 |
| Nutritional Studies and Diet | Lifetime | 616 | US 245 | 98.02 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 144 | US 82 | 96.62 |
| Hormonal Regulation and Hypertension | Lifetime | 599 | US 254 | 97.47 |
| Diabetes Treatment and Management | Lifetime | 619 | US 227 | 97.81 |
| Cardiac Arrhythmias and Treatments | Lifetime | 961 | US 435 | 97.74 |
| Cardiomyopathy and Myosin Studies | Lifetime | 505 | US 254 | 97.47 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 378 | US 175 | 96.78 |
| Viral Infections and Immunology Research | Lifetime | 800 | US 341 | 96.38 |
| Nitric Oxide and Endothelin Effects | Lifetime | 959 | US 422 | 96.66 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 57 | US 17 | 95.57 |
| Cardiovascular Issues in Pregnancy | Lifetime | 617 | US 263 | 95.63 |
| GDF15 and Related Biomarkers | Lifetime | 124 | US 44 | 92.96 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 878 | US 326 | 95.03 |
| Chronic Kidney Disease and Diabetes | Lifetime | 907 | US 360 | 95.43 |
| Renal function and acid-base balance | Lifetime | 671 | US 341 | 94.17 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 817 | US 126 | 89.52 |
| Renin-Angiotensin System Studies | Lifetime | 864 | US 334 | 93.28 |
| Coenzyme Q10 studies and effects | Lifetime | 774 | US 224 | 78.34 |
| Heart rate and cardiovascular health | Lifetime | 645 | US 196 | 70.27 |
| Cynara cardunculus studies | Lifetime | 441 | US 44 | 69.63 |
| Diet and metabolism studies | 2021-2025 | 18 | US 6 | 99.60 |
| Gut microbiota and health | 2021-2025 | 51 | US 7 | 99.31 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 50 | US 27 | 99.67 |
| Viral Infections and Immunology Research | 2021-2025 | 21 | US 7 | 98.36 |
| Heart Failure Treatment and Management | 2021-2025 | 38 | US 21 | 99.64 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 92 | US 39 | 98.73 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 124 | US 66 | 98.05 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 76 | US 36 | 98.06 |
| Potassium and Related Disorders | 2021-2025 | 17 | US 9 | 98.15 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 54 | US 26 | 97.57 |
| Mechanical Circulatory Support Devices | 2021-2025 | 204 | US 98 | 96.97 |
| Nutrition and Health in Aging | 2021-2025 | 359 | US 58 | 95.85 |
| Nutritional Studies and Diet | 2021-2025 | 328 | US 79 | 95.83 |
| Cardiovascular and exercise physiology | 2021-2025 | 213 | US 46 | 95.51 |
| Diabetes Treatment and Management | 2021-2025 | 384 | US 132 | 95.83 |
| Electrolyte and hormonal disorders | 2021-2025 | 64 | US 25 | 93.45 |
| Parathyroid Disorders and Treatments | 2021-2025 | 194 | US 53 | 93.48 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 462 | US 107 | 91.48 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 385 | US 131 | 92.58 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 85 | US 29 | 91.47 |
| BRCA gene mutations in cancer | 2021-2025 | 495 | US 228 | 88.44 |
| Congenital Heart Disease Studies | 2021-2025 | 760 | US 341 | 89.69 |
| Folate and B Vitamins Research | 2021-2025 | 273 | US 55 | 84.35 |
| Metabolism and Genetic Disorders | 2021-2025 | 480 | US 116 | 85.93 |
| Transplantation: Methods and Outcomes | 2021-2025 | 798 | US 455 | 87.44 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 470 | US 186 | 83.29 |
| Acute Kidney Injury Research | 2021-2025 | 557 | US 161 | 82.81 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 890 | US 198 | 79.59 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 532 | US 158 | 79.44 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 402 | US 101 | 76.00 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 565 | US 162 | 76.40 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 953 | US 334 | 73.03 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 764 | US 271 | 51.66 |